Apparent Regional Variation in MS Disability Progression in Sweden Reflects Clinic‐Level Heterogeneity
Acta Neurologica Scandinavica · 2026-01 · 2026 (1)
DOI: 10.1155/ane/4582085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neurologica Scandinavica, online erschienen am 03.06.2026. Verfasst von Anna Karin Hedström und 4 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet.
Abstract (Originalsprache)
Background
Geographic gradients in multiple sclerosis (MS) incidence are well described, but whether long‐term disability progression varies across regions, and to what extent clinic‐level factors contribute, remains unclear.
Methods
We included 8260 people with relapsing‐onset MS from two nationwide cohorts linked to the Swedish MS registry. Primary analyses focused on incident cases ( n = 3160), the full cohort was used for complementary analyses. The primary exposure was healthcare region (Stockholm–Gotland reference). Outcomes were confirmed disability worsening (CDW) and time to EDSS 3 and EDSS 4. Cox models estimated region‐specific hazard ratios (HRs) with 95% confidence intervals (CI). Shared‐frailty models with clinic as a random effect accounted for within‐region clinic heterogeneity. Within‐region contrasts compared the three largest clinics in selected regions (anonymized). Two‐sided p values < 0.05 were considered statistically significant. Analyses were performed using SAS version 9.4.
Results
In incident cases, the Northern and Western regions showed consistently lower risks of CDW and of reaching EDSS 3 and EDSS 4 than Stockholm–Gotland. The South‐Eastern region had a lower risk for CDW (HR 0.74, 95% CI 0.59–0.94). After accounting for clinic‐level heterogeneity, regional contrasts attenuated and were no longer significant, as illustrated by the South‐Eastern region (HR 0.87, 95% CI 0.59–1.18). The full cohort showed similar geographic patterns. Within‐region clinic comparisons revealed substantial heterogeneity despite a shared regional context.
Conclusions
Apparent regional variation in long‐term MS disability progression in Sweden largely reflects between‐clinic differences rather than broad geographic gradients. Observed differences between clinics may reflect contributions from lifestyle‐related factors, clinic practices, and other unmeasured influences.
Förderung
- Vetenskapsrådet
Zitieren
APA
Hedström, A. K., Guo, J., Johansson, E., Olsson, T., & Alfredsson, L. (2026). Apparent Regional Variation in MS Disability Progression in Sweden Reflects Clinic‐Level Heterogeneity. Acta Neurologica Scandinavica, 2026(1). https://doi.org/10.1155/ane/4582085
Vancouver
Hedström AK, Guo J, Johansson E, Olsson T, Alfredsson L. Apparent Regional Variation in MS Disability Progression in Sweden Reflects Clinic‐Level Heterogeneity. Acta Neurologica Scandinavica. 2026;2026(1). doi:10.1155/ane/4582085
BibTeX
@article{Hedstrm2026,
author = {Hedström, Anna Karin and Guo, Jie and Johansson, Eva and Olsson, Tomas and Alfredsson, Lars},
title = {Apparent Regional Variation in MS Disability Progression in Sweden Reflects Clinic‐Level Heterogeneity},
journal = {Acta Neurologica Scandinavica},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ane/4582085}
}
EUVIMED